NEWPORT NEWS, Va., Feb. 3 /PRNewswire/ -- Dilon Technologies, Inc., a leader in molecular breast imaging, today announced the release of two new collimators: the Slant15 Collimator for breast imaging and the Low Energy High-Resolution (LEHR) Collimator. Both collimators are attachment options for the Dilon 6800 Gamma Camera that help to optimize imaging for the respective applications.
The Slant15 Collimator is a 15-degree slant parallel-hole collimator that minimizes the dead space along the edge of the detector, allowing better visualization of the chest wall in breast imaging. Uses include: breast imaging; sentinel node imaging; thyroid imaging; and parathyroid imaging.
LEHR collimator is a high-resolution collimator for general nuclear medicine applications. Uses include thyroid imaging, parathyroid imaging, sentinel node imaging, spot bone imaging, gall bladder ejection, and pediatric imaging studies.
"With the release of these new collimators, we are expanding breast imaging and general nuclear applications for the Dilon 6800 Gamma," said Bob Moussa, President and CEO of Dilon Technologies. "This is another step in providing a broader service offering to clinicians."
About Dilon Technologies
Dilon Technologies, Inc. is bringing innovative new medical imaging products to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform BSGI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; and The Rose, Houston.
For more information on Dilon Technologies please visit http://www.dilon.com.
CONTACT: Nancy F. Morter of Dilon Technologies, Inc., +1-757-269-4910,
ext. 302, cell, +1-757-589-3914, nfmorter@dilon.com
Web site: http://www.dilon.com/
